Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Case report.
The patient was the only child of healthy, unrelated parents. During gestation a cleft lip and palate were detected. The fetal karyotype was considered normal. Vaginal delivery was at 39 weeks. Birth weight was 2,750 g and length was 49 cm. Additional dysmorphic features included microcephaly, downslanting and small palpebral fissures, abnormal external ears with thick helix, single palmar creases bilaterally, and partial syndactyly between the second and third toes. Neurologic examination was normal. Cardiologic examination revealed a small interventricular communication. A new karyotype detected a deletion at chromosome 2q24 (data not shown).
She first had epileptic seizures at age 2 months, which were predominantly tonic and asymmetric, involved the left or right limb and face, and were accompanied by severe apnea and cyanosis. Seizures were brief and responded temporarily to phenobarbital. She subsequently had multiple seizures and status epilepticus lasting 2 to 3 days and occurring in clusters. Seizure-free intervals lasted 4 days to 3 weeks. Within a few months the seizure pattern became clonic, multifocal, and migratory. Neurologic and developmental assessment became abnormal at age 2 months. Visual behavior was abnormal with no consistent fixation or tracking. Response to sounds was questionable, and suction was poor. She had poor …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancyL. B. Holmes, E. J. Baldwin, C. R. Smith et al.Neurology, April 30, 2008 -
Articles
Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancyF. Madia, P. Striano, E. Gennaro et al.Neurology, October 09, 2006 -
Articles
Andersen–Tawil syndromeNew potassium channel mutations and possible phenotypic variationN. P. Davies, P. Imbrici, D. Fialho et al.Neurology, October 10, 2005 -
Articles
Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?H. Dolk, J. Jentink, M. Loane et al.Neurology, July 23, 2008